Polaris Venture Management Co IV
Latest statistics and disclosures from Polaris Venture Management Co IV's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Acceleron Pharma, Alimera Sciences, Pulmatrix, Cerulean Pharma, and represent 100.00% of Polaris Venture Management Co IV's stock portfolio.
- Polaris Venture Management Co IV has $62M in assets under management (AUM), dropping by 3.41%.
- Central Index Key (CIK): 0001295438
Portfolio Holdings for Polaris Venture Management Co IV
Polaris Venture Management Co IV holds 4 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Acceleron Pharma | 85.8 | $54M | 1.5M | 36.19 |
|
|
| Alimera Sciences | 7.5 | $4.7M | 3.1M | 1.49 |
|
|
| Pulmatrix | 4.2 | $2.6M | 1.6M | 1.65 |
|
|
| Cerulean Pharma | 2.4 | $1.5M | 1.4M | 1.05 |
|
Past Filings by Polaris Venture Management Co IV
SEC 13F filings are viewable for Polaris Venture Management Co IV going back to 2013
- Polaris Venture Management Co IV 2016 Q2 filed Feb. 14, 2017
- Polaris Venture Management Co IV 2016 Q3 filed Feb. 14, 2017
- Polaris Venture Management Co IV 2016 Q1 filed May 13, 2016
- Polaris Venture Management Co IV 2015 Q4 filed Feb. 16, 2016
- Polaris Venture Management Co IV 2015 Q3 filed Nov. 10, 2015
- Polaris Venture Management Co IV 2015 Q2 filed Aug. 11, 2015
- Polaris Venture Management Co IV 2015 Q1 filed May 14, 2015
- Polaris Venture Management Co IV 2014 Q4 filed Feb. 17, 2015
- Polaris Venture Management Co IV 2014 Q3 filed Oct. 23, 2014
- Polaris Venture Management Co IV 2014 Q2 filed Aug. 11, 2014
- Polaris Venture Management Co IV 2014 Q1 filed May 1, 2014
- Polaris Venture Management Co IV 2013 Q4 filed Feb. 14, 2014